Close Menu

NEW YORK (GenomeWeb) – Phenomix Sciences — an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases — announced today that it is launching a $1 million seed financing round through a crowdfunding platform.

The privately held firm said it intends to use the financing to commercialize a new clinical test for obesity. The diagnostic uses technology developed by the Mayo Clinic to analyze metabolomic and DNA biomarkers to characterize obesity and guide more effective weight loss treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.